New three-in-one blood test opens door to precision medicine for prostate cancer

Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate cancer through use of precision drugs designed to target mutations in the BRCA genes. This follows last week's announcement of a blood test for...

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2rFTwgz
via IFTTT